Patent ID: 7972626

Claim:
A nasal pharmaceutical formulation comprising an aqueous suspension of a therapeutically effective amount of fluticasone, wherein the formulation comprises 0.05% by weight of solid fluticasone propionate particles having the following particle size distribution profile: (i) about 10% of the fluticasone particles have a particle size of less than 0.4 microns; (ii) about 25% of the fluticasone particles have a particle size of less than 0.8 microns; (iii) about 50% of the fluticasone particles have a particle size of less than 1.5 microns; (iv) about 75% of the fluticasone particles have a particle size of less than 3.0 microns; and (v) about 90% of the fluticasone particles have a particle size of less than 5.3 microns, and wherein the fluticasone is suitable for intranasal administration to an individual.